EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of maternal allergy and supplementation with ω‐3 fatty acid and probiotic on human milk oligosaccharides

Ahmed Al-Kaabawi iD, Eva Landberg, Magalí Martí, Elisabet Severin, Lina Tingö iD, Karel Duchén, Maria C Jenmalm iD

Pediatric Allergy and Immunology · 2025

DOI: 10.1111/pai.70162 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Allergy and Immunology, 2025. Verfasst von Ahmed Al-Kaabawi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden. Hauptthemen laut MEDLINE: Milk, Human, Oligosaccharides, Probiotics, Fatty Acids, Omega-3. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine and Health Sciences at Linköping University, Insamlingsstiftelsen Cancer- och Allergifonden, Joanna Cocozza Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human milk oligosaccharides (HMOs) are complex carbohydrates that act as prebiotics, supporting infants' gut microbial colonization and immune development. HMO levels are influenced by several maternal factors, including genetics, diet, and health status. In this study, we aim to investigate the effects of ω‐3 PUFA (polyunsaturated fatty acids) and Limosilactobacillus ( L .) reuteri supplementation on HMO levels in colostrum and mature milk. Another aim is to compare HMO levels between allergic and non‐allergic mothers and to explore the correlation between HMOs and secretory immunoglobulin A (SIgA) in milk.

Methods

Milk samples ( n = 136) were collected from mothers enrolled in a clinical trial (PROOM‐3) designed to investigate the effect of pre‐ and postnatal supplementation with ω‐3 PUFA and L. reuteri on allergy development in early childhood. HMOs were measured in colostrum and mature milk collected 3 months postpartum using high‐performance anion exchange chromatography. SIgA was measured in colostrum, 1‐, 2‐, 3‐, and 4‐month milk using ELISA.

Results

The supplements did not affect HMO levels in colostrum or mature milk. However, maternal supplementation with ω‐3 PUFA decreased the HMO diversity over time. Additionally, allergic mothers expressed significantly lower levels of several HMOs compared to non‐allergic mothers. Additionally, SIgA correlated positively with fucosylated and negatively with sialylated HMOs.

Conclusion

Supplementation with ω‐3 PUFA could reduce the HMO diversity over the course of lactation. Also, maternal allergy seems to be associated with a reduction in levels of several HMOs. Furthermore, there is a possible dynamic interplay between HMOs and SIgA in milk. Trial Registration ClinicalTrials.gov ‐ID: NCT01542970

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Milk, HumanOligosaccharidesProbioticsFatty Acids, Omega-3Limosilactobacillus reuteriHypersensitivityHumansFemaleDietary SupplementsColostrumAdultInfantImmunoglobulin A, Secretory

Stichwörter der Autor:innen

Limosilactobacillus reutericlinical trialhuman milkhuman milk oligosaccharidesmaternal allergysecretory immunoglobulin aω‐3 polyunsaturated fatty acids

Substanzen

OligosaccharidesFatty Acids, Omega-3Immunoglobulin A, Secretory

Autor:innen und Institutionen

  • Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden.
  • Department of Clinical Chemistry, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Department of Biomedical and Clinical Sciences, Division of Children's and Women's Health, Linköping University, Linköping, Sweden.
  • Allergy Center, University Hospital, Linköping, Sweden.

ORCID-Profile: Ahmed Al-Kaabawi, Lina Tingö, Maria C Jenmalm

Förderung

  • Faculty of Medicine and Health Sciences at Linköping University
  • Insamlingsstiftelsen Cancer- och Allergifonden
  • Joanna Cocozza Foundation
  • Hjärt-Lungfonden
  • Vetenskapsrådet

Zitieren

APA

Al-Kaabawi, A., Landberg, E., Martí, M., Severin, E., Tingö, L., Duchén, K., & Jenmalm, M. C. (2025). Effects of maternal allergy and supplementation with ω‐3 fatty acid and probiotic on human milk oligosaccharides. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.70162

Vancouver

Al-Kaabawi A, Landberg E, Martí M, Severin E, Tingö L, Duchén K, et al. Effects of maternal allergy and supplementation with ω‐3 fatty acid and probiotic on human milk oligosaccharides. Pediatric Allergy and Immunology. 2025. doi:10.1111/pai.70162

BibTeX
@article{AlKaabawi2025,
  author = {Al-Kaabawi, Ahmed and Landberg, Eva and Martí, Magalí and Severin, Elisabet and Tingö, Lina and Duchén, Karel and Jenmalm, Maria C},
  title = {Effects of maternal allergy and supplementation with ω‐3 fatty acid and probiotic on human milk oligosaccharides},
  journal = {Pediatric Allergy and Immunology},
  year = {2025},
  doi = {10.1111/pai.70162}
}
Kostenlos starten →